Literature DB >> 7929118

Identification of the nature of modification that causes the shift of DNA topoisomerase II beta to apparent higher molecular weight forms in the M phase.

K Kimura1, N Nozaki, M Saijo, A Kikuchi, M Ui, T Enomoto.   

Abstract

Human cell lines express two genetically distinct isoforms of DNA topoisomerase (topo II) II: topo II alpha (p170) and topo II beta (p180). We detected a higher molecular weight form with an apparent molecular mass of about 190 kDa in M phase-arrested HeLa cells (Kimura, K., Saijo, M., Ui, M., and Enomoto, T. (1994) J. Biol. Chem. 269, 1173-1176). In this study we confirmed, using anti-topo II alpha and topo II beta monoclonal antibodies, that this higher molecular weight form is topo II beta and consists of doublet bands around 190 kDa. We confirmed that the doublet bands constituted an M phase-specific phenomenon and were not an artifact of the procedure used to accumulate mitotic cells. Digesting the immunoprecipitated materials from mitotic cell extracts with alkaline phosphatase resulted in the disappearance of the doublet bands and the appearance of the 180-kDa band with the concomitant disappearance of 32P label in the region of the doublet bands. Neither heat-inactivated alkaline phosphatase nor phosphodiesterase affected the doublet bands and the 32P label. Topo II beta in interphase cells was also phosphorylated, but the shift in apparent molecular weight was very slight after alkaline phosphatase digestion. Analysis of the labeled phosphoamino acids present in topo II beta from M phase and logarithmically growing cells indicated that phosphorylation occurred mainly on serine and fairly on threonine residues in both topo II beta isoforms. These results indicated that topo II beta is phosphorylated at specific sites in M phase, resulting in the formation of the doublet bands.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929118

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Organization of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells.

Authors:  N Chaly; X Chen; J Dentry; D L Brown
Journal:  Chromosome Res       Date:  1996-09       Impact factor: 5.239

2.  Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.

Authors:  P S Shapiro; A M Whalen; N S Tolwinski; J Wilsbacher; S J Froelich-Ammon; M Garcia; N Osheroff; N G Ahn
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms.

Authors:  H Biersack; S Jensen; I Gromova; I S Nielsen; O Westergaard; A H Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Immunohistochemical study of DNA topoisomerase II in human gastric disorders.

Authors:  N Yabuki; H Sasano; K Kato; S Ohara; T Toyota; H Nagura; M Miyaike; N Nozaki; A Kikuchi
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  Survey for human polyomaviruses in cancer.

Authors:  Tuna Toptan; Samuel A Yousem; Jonhan Ho; Yuki Matsushima; Laura P Stabile; Maria-Teresa Fernández-Figueras; Rohit Bhargava; Akihide Ryo; Patrick S Moore; Yuan Chang
Journal:  JCI Insight       Date:  2016-02-25

6.  AMP-activated protein kinase-mediated feedback phosphorylation controls the Ca2+/calmodulin (CaM) dependence of Ca2+/CaM-dependent protein kinase kinase β.

Authors:  Akihiro Nakanishi; Naoya Hatano; Yuya Fujiwara; Arian Sha'ri; Shota Takabatake; Hiroki Akano; Naoki Kanayama; Masaki Magari; Naohito Nozaki; Hiroshi Tokumitsu
Journal:  J Biol Chem       Date:  2017-10-03       Impact factor: 5.157

7.  Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.

Authors:  Yutaro Yamaoka; Kei Miyakawa; Sundararaj Stanleyraj Jeremiah; Rikako Funabashi; Koji Okudela; Sayaka Kikuchi; Junichi Katada; Atsuhiko Wada; Toshiki Takei; Mayuko Nishi; Kohei Shimizu; Hiroki Ozawa; Shuzo Usuku; Chiharu Kawakami; Nobuko Tanaka; Takeshi Morita; Hiroyuki Hayashi; Hideaki Mitsui; Keita Suzuki; Daisuke Aizawa; Yukihiro Yoshimura; Tomoyuki Miyazaki; Etsuko Yamazaki; Tadaki Suzuki; Hirokazu Kimura; Hideaki Shimizu; Nobuhiko Okabe; Hideki Hasegawa; Akihide Ryo
Journal:  Cell Rep Med       Date:  2021-05-16

8.  Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.

Authors:  Lauren Gardner; Rohit Malik; Yoshiko Shimizu; Nicole Mullins; Wael M ElShamy
Journal:  Breast Cancer Res       Date:  2011-05-19       Impact factor: 6.466

9.  Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.

Authors:  Adrian G Grozav; Kenichi Chikamori; Toshiyuki Kozuki; Dale R Grabowski; Ronald M Bukowski; Belinda Willard; Michael Kinter; Anni H Andersen; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Nucleic Acids Res       Date:  2008-11-29       Impact factor: 16.971

10.  A novel histone exchange factor, protein phosphatase 2Cgamma, mediates the exchange and dephosphorylation of H2A-H2B.

Authors:  Hiroshi Kimura; Nanako Takizawa; Eric Allemand; Tetsuya Hori; Francisco J Iborra; Naohito Nozaki; Michiko Muraki; Masatoshi Hagiwara; Adrian R Krainer; Tatsuo Fukagawa; Katsuya Okawa
Journal:  J Cell Biol       Date:  2006-10-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.